|
Delayed
Nasdaq
00:00:00 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 8.08B 7.39B 6.74B 12.71B 847B 13.11B 89.05B 35.51B 452B 33.83B 33.1B 1,427B | P/E 2024 |
-13.8x | P/E 2025 | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 8.03B 7.21B 6.58B 6.01B 11.33B 755B 11.68B 79.37B 31.65B 403B 30.15B 29.51B 1,272B | EV / Sales 2024 |
3,310x | EV / Sales 2025 | 447x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
CBOE
| CRNX | Real-time |
Last Transcript: Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 3 months | +1.23% | ||
| 6 months | +103.67% | ||
| Current year | +82.49% |
| Current year | 32.3 |  | 85.01 |
| 1 year | 32.3 | | 85.01 |
| 3 years | 24.1 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 01/09/2026 |
Cory Jubinville
PRN | Corporate Officer/Principal | - | 01/02/2026 |
Omar White
SEC | Corporate Secretary | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 01/09/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 01/09/26 | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 01/09/26 | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.04M 932K 852K 777K 1.46M 97.67M 1.51M 10.27M 4.09M 52.11M 3.9M 3.82M 165M | 7.7M 6.9M 6.31M 5.76M 10.85M 723M 11.19M 76.04M 30.32M 386M 28.89M 28.27M 1.22B |
| Net income | -298M -268M -245M -223M -421M -28.05B -434M -2.95B -1.18B -14.97B -1.12B -1.1B -47.25B | -465M -417M -381M -348M -656M -43.74B -677M -4.6B -1.83B -23.34B -1.75B -1.71B -73.68B |
| Net Debt | -1.3B -1.17B -1.07B -974M -1.84B -122B -1.89B -12.87B -5.13B -65.32B -4.89B -4.78B -206B | -979M -878M -803M -733M -1.38B -92.06B -1.42B -9.68B -3.86B -49.12B -3.68B -3.6B -155B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
